Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Sebacia logo — Sebacia Microparticles is a novel FDA-cleared acne treatment...

Sebacia

Sebacia Microparticles is a novel FDA-cleared acne treatment, representing the newest innovation in acne in two decades

Founded 2010 United States Duluth, United States 1 employees Venture round Total: $101.59M Biotechnology, Medical Devices

General Information

Company Name Sebacia
Founded Year 2010
Location United States Duluth, United States
Employees 1
Industries Biotechnology, Medical Devices
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with Sebacia. To contact Sebacia, visit sebacia.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

About Sebacia

Sebacia is a U.S. based biotechnology startup founded in 2010. The company's flagship product, Sebacia Microparticles, offers a novel FDA-cleared treatment for acne, marking the latest advancement in acne treatment in two decades. Utilizing patented technology developed in collaboration with Rice University and the Wellman Center of Photomedicine at Massachusetts General Hospital, the microparticles are designed to selectively target and heat oil-producing glands, addressing a root cause of acne lesions. Sebacia aims to provide a superior alternative to conventional topical and systemic drugs for acne. The U.S. FDA's clearance for Sebacia Microparticle followed a successful pivotal study, demonstrating its clinical efficacy and safety. The company secured a $10.00M Venture Round investment on August 30, 2019, signifying confidence in its innovative approach to acne treatment. With its focus on dermatology and aesthetics, Sebacia has the potential to disrupt the acne treatment market. By leveraging its advanced technology and FDA clearance, the company stands at the forefront of revolutionizing acne treatment. More information about Sebacia Microparticles and its commercialization plans in the U.S. can be found on their website www.sebacia.com. Based in Duluth, Georgia, the company is poised to make a significant impact in the biotechnology and dermatology sectors.

Taxonomy: medical device, dermatology, acne treatment, aesthetics, FDA-cleared, microparticles technology, topical therapies, dermatological conditions, breakthrough treatment, Rice University, Wellman Center of Photomedicine, proprietary technology, clinical efficacy, safety clearance, commercialization

Funding Rounds & Investors (10)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round $10.00M -
30 Aug 2019
Debt Financing $16.00M 1
Hercules Capital
Hercules Capital
25 Jul 2017
Series D $20.00M 5
Accuitive Medical Ventures Domain Associates Versant Ventures
Accuitive Medical Ventures, Domain Associates +3
25 Jul 2017
Series C $12.00M 4
Accuitive Medical Ventures Domain Associates Versant Ventures
Accuitive Medical Ventures, Domain Associates +2
25 Jun 2015
Debt Financing $10.00M 1
Square 1 Bank
Square 1 Bank
25 Jun 2015
Venture Round $8.00M -
02 Jun 2015
Venture Round $11.00M -
12 Jun 2014
Series B $6.50M -
03 Jul 2013
Series A $5.59M -
01 Jun 2011
Debt Financing $2.50M -
11 Jun 2010

Sebacia Alternatives & Competitors

View All Alternatives
Sebacia vs
Impulse Dynamics
Impulse Dynamics United States

A cardiac medical device company determined to improve the lives of heart failure patients through C...

Venture round
239 employees
Biotechnology, Health Care
Sebacia vs
ANGLE
ANGLE United Kingdom

The leading experts in cancer cell capture and analysis from liquid biopsies

Post-IPO Equity
165 employees
Biotechnology, Health Care
Sebacia vs
hemotune AG
hemotune AG Switzerland

We are a Swiss company on a mission to combat sepsis through magnetic blood purification. Member of...

Series B
25 employees
Biotechnology, Health Care
View all alternatives

FAQ About Sebacia

Sebacia Microparticles is a novel FDA-cleared acne treatment, representing the newest innovation in acne in two decades
Sebacia was founded in 2010.
Sebacia is headquartered in Duluth, United States.
Sebacia operates in Biotechnology and Medical Devices. Its work centres on medical device, dermatology, acne treatment and aesthetics.
Sebacia has approximately 1 employees.
Sebacia has completed 10 funding rounds, raising a total of $101.59M. The latest funding stage is Venture round.
Top alternatives and competitors to Sebacia include Impulse Dynamics, ANGLE, hemotune AG, Rhaeos. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Sebacia and Impulse Dynamics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Sebacia, https://bouncewatch.com/company/sebacia, updated 28 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes